https://evaluate.com

Pharma commercial intelligence, news & analysis | EvaluateTrusted commercial intelligence, consensus forecasts, Vantage news and analysis for pharma, biotech and medtech industry - Explore EvaluatePharma commercial intelligence, news & analysis | Evaluate --> Skip to content Need pharma insights? Register for Evaluate Discovery NEWSLETTER SIGN-UP Search Search Close this search box. Subscriber Log In Menu Subscriber Log In Search Search Subscriber Log In How We Help Asset Screening Competitive Landscape Analysis Commercial Opportunity Assessment Company Profiling Deal Benchmarking Market Opportunity Sizing Asset & Portfolio Strategy Business Development & Licensing Solutions Products Evaluate Pharma Evaluate Omnium Japan Drug Forecasts Europe Drug Forecasts Evaluate Epi Evaluate Medtech CDMO Intelligence J+D Forecasting Solutions BioSciDB Competitive Intelligence Real-World Data Consulting & Analytics Consulting & Analytics Data Feeds Resources News & Events Thought Leadership Webinars About Careers Meet Our Team What Sets Us Apart Contact Menu How We Help Asset Screening Competitive Landscape Analysis Commercial Opportunity Assessment Company Profiling Deal Benchmarking Market Opportunity Sizing Asset & Portfolio Strategy Business Development & Licensing Solutions Products Evaluate Pharma Evaluate Omnium Japan Drug Forecasts Europe Drug Forecasts Evaluate Epi Evaluate Medtech CDMO Intelligence J+D Forecasting Solutions BioSciDB Competitive Intelligence Real-World Data Consulting & Analytics Consulting & Analytics Data Feeds Resources News & Events Thought Leadership Webinars About Careers Meet Our Team What Sets Us Apart Contact Billion Dollar Blueprint: The Journey to Blockbuster Status What’s the secret formula for creating the next pharmaceutical behemoth? In this eBook discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.  DOWNLOAD NOW Are orphan drugs losing their sparkle? For more than a decade, orphan drugs’ growth has outpaced that of non-orphan prescription drugs. But the growth gap is narrowing… DOWNLOAD THE NEW REPORT NOW Orphan Drugs Webinar. Are They Losing Their Sparkle? Building on the insights from the Evaluate Orphan Drugs 2024 report, our upcoming webinar will explore key findings in greater detail, offering expert perspectives on the evolving market dynamics. WATCH NOW Evaluate World Preview 2024: Pharma's Growth Boost Last year’s Age of Uncertainty has given way to more predictable realities, including the dominance of obesity and other big diseases, a wider range of modalities and an IRA that’s here to stay. Check out all the data and analysis in the new report. DOWNLOAD NOW EVALUATING: Radiopharmaceuticals In this eBook, we explore the latest science, dealmaking, and commercial opportunities in the radiopharmaceutical landscape, highlighting some of its most intriguing players. DOWNLOAD NOW Evaluate radically transforms your confidence in strategic portfolio decisions. In biopharma, making the right decisions has an incredible impact on patients’ lives. Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines. Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real world data, and deep expertise to help you make portfolio decisions that drive growth. HOW WE HELP Connected data gives you a clearer picture. Evaluate gives you the understanding and time you need to drive better decisions. Market Opportunity Sizing Identify the market that offers the greatest potential for your business so you can confidently prioritise assets and allocate resources. Find Out More Commercial Opportunity Assessment Develop a robust view of potential partners and licensing opportunities to boost your pipeline and amplify your commercial success. Find Out More Competitive Landscape Analysis Build a clear analysis of the evolving landscape – market dynamics, emerging trends and key players – and make strategic moves that strengthen your position. Find Out More Company Profiling Monitor key companies so you can track potential partners and competitors and find opportunities in a constantly changing environment. Find Out More Asset Screening Obtain a clear and unbiased assessment of asset value to drive licensing decisions and ensure you invest in assets with the highest potential for success. Find Out More Deal Benchmarking Bring confidence to your allocation strategy with timely external benchmarking data across the R&D landscape. Find Out More We collect, collaborate and connect. OUR SOLUTIONS Insight at Your Fingertips Access our world-class forecasting, analysis and machine learning-driven insight to help you reduce risk, maximise returns, and make smarter decisions about your portfolio strategy. LEARN MORE MARKET REPORTS Trends & Analysis Dive into our market reports covering sector performance and valuation, emerging trends and global forecasts. Stay ahead of the competition with the latest developments that impact your portfolio strategy. LEARN MORE OUR SERVICES Consulting & Analytics Tap into our expertise and reach your goals with our collaborative team of specialists, providing technology-enabled consulting, strategic commercial insights, and recommendations across the product lifecycle. LEARN MORE Latest Solutions & Insights Understand the context. Data-driven insights and analysis for the pharma, biotech and medtech sectors. August 8, 2024 Meet the Team: Kelly Chamberlain Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella, ... August 6, 2024 In Case You Missed It: Three Things we Learned in our AI Forecasting Webinar If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re ... July 24, 2024 Unlocking the Power of AI in Pharmaceutical Forecasting There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by ... July 18, 2024 In Case You Missed It: Three Things we Learned in our World Preview Webinar Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of ... July 16, 2024 Using Sales-Based Forecasting to Identify Opportunity and Risk for Pharma Business Can Forecasting Help Identify Market Opportunities for Pharmaceutical Companies? Forecasting serves to help pharmaceutical companies identify market opportunities, particularly when taking a sales-based approach and considering the wider competitive set. ... July 8, 2024 The Processes Needed for Successful Pharmaceutical Forecasting Many pharmaceutical companies are harnessing digital solutions to elevate global forecasting. Digital tools, such as cloud-based, SaaS environments, are powering efficient, streamlined, and intelligent forecasting processes. But, for technological solutions ... Ready to learn more? Contact us today to get started. Area of Interest Call Back Careers Demo Evaluate Consulting Services Evaluate Products & Services Media Enquiry Other Country I would like to receive Evaluate industry & market reports, and the latest news from Evaluate. Your information will be used in accordance with our Privacy notice. How We Help Solutions About Resources Careers Humberger Toggle Menu How We Help Solutions About Resources Careers Humberger Toggle Menu Contact Terms and Conditions Privacy Policy Modern Slavery Statement Cookie Policy Humberger Toggle Menu Contact Terms and Conditions Privacy Policy Modern Slavery Statement Cookie Policy Humberger Toggle Menu Linkedin Instagram Copyright © 2024 Evaluate, a Norstella Company How We Help Asset Screening Competitive Landscape Analysis Commercial Opportunity Assessment Company Profiling Deal Benchmarking Market Opportunity Sizing Asset & Portfolio Strategy Business Development & Licensing Solutions Products Evaluate Pharma Evaluate Omnium Japan Drug Forecasts Europe Drug Forecasts Evaluate Epi Evaluate Medtech CDMO Intelligence J+D Forecasting Solutions BioSciDB Competitive Intelligence Real-World Data Consulting & Analytics Consulting & Analytics Data Feeds Resources News & Events Thought Leadership Webinars About Careers Meet Our Team What Sets Us Apart Contact Linkedin Instagram Terms and Conditions Privacy Policy Modern Slavery Statement Cookies Policyenusen-US1726603094https://evaluate.com

Bearbeiten Sie Ihre Website?

Was machst du?